Formulation and stability testing of photolabile drugs

International Journal of Pharmaceutics

Volumn 225, Issue 1-2, 2001, Pages 1-14

  Tønnesen, Hanne Hjorth ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Formulation; Photolabile drugs; Stability testing

Indexed keywords

ADRENALIN; ALGINIC ACID; ALPHA TOCOPHEROL; AMINOQUINOLINE DERIVATIVE; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CARBAMAZEPINE; CHELATING AGENT; CHLOROQUINE; CIPROFLOXACIN; COLORING AGENT; CROSPOVIDONE; CYCLODEXTRIN; DAUNORUBICIN; DRUG; EXCIPIENT; FUROSEMIDE; ISOPRENALINE; LIPOSOME; MEFLOQUINE; MOLSIDOMINE; NITRAZEPAM; NITROFURAL; NORADRENALIN; PHENOBARBITAL; POVIDONE; SWEETENING AGENT; TOPICAL AGENT; UNINDEXED DRUG;

DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG PACKAGING; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; PHOTODEGRADATION; PHOTOREACTIVITY; PHOTOSENSITIVITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RADIATION EXPOSURE; REACTION ANALYSIS; REVIEW; SPECTRAL SENSITIVITY; TABLET FORMULATION; ULTRAVIOLET IRRADIATION;

CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; EXCIPIENTS; PHOTOCHEMISTRY;

EID: 0035964447     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00746-3     Document Type: Review

References (94)

1. Photochemistry of drugs: An overview an practical problems
2. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 2. Colchicine
3. Photochemical decomposition of midazolam. IV. Study of pH-dependent stability by high-performance liquid chromatography
4. Influence of certain additives on the photostabilizing effect of uric acid for solutions of FD and C blue no.2
5. Influence of certain additives on the photostabilizing effect of dimethyl sulfoxide for sodium nitroprusside solutions
6. Influence of certain additives on the photostability of physostigmine sulfate solutions
7. Effect of certain additives on photodegradation of tetracycline hydrochloride solutions
8. Effect of sodium thiosulphate on the photolysis of phenobarbital: Evidence of complex formation
9. Film coating: Effect of titanium dioxide concentration and film thickness on the photostability of nifedipine
10. Medicinal photochemistry: Phototoxic and phototherapeutic aspects of drugs
11. Fast laser-induced solute release from liposomes sensitized with photochromic lipid: Effects of temperature, lipid host, and sensitizer concentration
12. Active uptake of drugs into photosensitive liposomes and rapid release on UV photolysis
13. Degradation of glucose in the presence of electrolytes during heat sterilization
14. Photodestabilization of epinephrine by sodium metabisulfite
15. Stability of solids and solid dosage forms
16. Microcapsules prepared from alginate and a photosensitive poly(L-lysine)
17. Photostability profiles of minoxidil solutions
18. Photochemical decomposition of 1,4-benzodiazepines. Nitrazepam
19. Photostabilization of uncoated tablets of sorivudine and nifedipine by incorporation of synthetic iron oxides
20. Photochemical decomposition of chloramphenicol in a 0.25% eyedrop and in a therapeutic intraocular concentration
21. Kinetic study of the solid state photolytic degradation of two polymorphic forms of furosemide
22. Autoxidation of polysorbates
23. Relevant literature on photostability testing of actual drug substances and drug formulations
24. Is the photodecomposition of drugs predictable?
25. Photodecomposition of drugs
26. Complex formation between metronidazole and sodium urate: Effect on photodegradation of metronidazole
27. Photostabilization of riboflavin by incorporation into liposomes
28. Novel caged compounds of hydrolysis-resistant 8-Br-cAMP and 8-Br-cGMP: Photolabile NPE esters
29. Photsensitizer delivery mediated by macromolecular carrier systems
30. Effect of sweetening agents on the light stability of aqueous solutions of L-ascorbic acid
31. Inconsistencies and defiencies which exist in the current official regulations concerning the photolytic degradation of drugs
32. Impurities in new drug substances
33. Photostability testing of new drug substances and products
34. Impurities in new drug products
35. Photoprotection of daunorubicin hydrochloride with sodium sulfite
36. Reaction of haloperidol with 5-(hydroxymethyl)-2-furfuraldehyde, an impurity in anhydrous lactose
37. Photochemistry of naproxen in the presence of β-cyclodextrin
38. Low-density lipoproteins-liposome delivery systems for tumor photosensitizers in vivo
39. Light-activated drugs and drug formulations in drug targeting
40. Photoresponsive membrane systems
41. Irradiation of titanium dioxide generates both singlet oxygen and superoxide anion
42. Photoreactivity of biologically active compounds XIV. Influence of oxygen on light induced reactions of primaquine
43. Mechanism of the photofading of dye. Contribution of singlet oxygen in the catalytic fading of anthraquinone dye mixtures
44. 2-Hydroxypropyl-β-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid
45. Novel liposome-based multicomponent system for the protection of photolabile agents
46. A novel cell encapsulation method using photosensitive poly(allylamine alpha-cyanocinnamylideneacetate)
47. Effect of cyclodextrin complexation on aqueous solubility and photostability of phenothiazine
48. Kinetic analysis of nifedipine photodegradation in the solid state
49. Stability of UV filters in different vehicles: Solvents and emulsions
50. Pharmaceutical evaluation of carbamazepine modifications: Comparative study for photostability of carbamazepine polymorphs by using Fourier-transformed reflection-absorption infrared spectroscopy and colorimetric measurement
51. Addressing the problem of light instability during formulation development
52. Photochemical stability of the inclusion complexes of nicardipine with α-, γ-cyclodextrin, methyl-β-cyclodextrin and hydroxypropyl-β-cyclodextrin in the solid state and in solution
53. Standardization of photodegradation studies and kinetic treatment of photochemical reactions
54. Photophysical and photochemical aspects of drug stability
55. Determining the kinetics and mechanism of a photochemical reaction
56. Fast solute release from photosensitive liposomes: An alternative to "caged" reagents for use in biological systems
57. Photoreactivity of biologically active compounds. XII. Photostability of polymorphic modifications of chloroquine diphosphate
58. Photoreactivity of biologically active compounds. X: Photoreactivity of chloroquine in aqueous solution
59. Photo-sensitive lipid membrane perturbation by a single chain lipid having terminal spiropyran group
60. Photostabilitätsuntersuchungen an natrium-warfarin in kristallinem zustand
61. Peroxides in polyethylene glycols and polyethylene glycol derivatives
62. Mathematical models for studies of photochemical reactions
63. Penetration of vitamin A acid into human skin
64. Photolability of nitrofurazone in aqueous solution. II. Kinetic studies
65. Effect of food dyes on the photostability of aqueous solutions of L-ascorbic acid
66. The role of commercial pigments in the photodegradation of poly (vinyl chloride) (PVC)
67. The influence of reducing substances on the rate of degradation of alginates
68. Triplet photochemistry of suprofen in aqueous environment and in the β-cyclodextrin inclusion complex
69. Effect of β-cyclodextrin complexation on the photochemical and photosensitizing properties of tolemtin: A steady state and time resolved study
70. The photochemistry of flutamide and its inclusion complex with β-cyclodextrin. Dramatic effect of the microenvironment on the nature and on the efficiency of the photodegradation pathways
71. Signal sensitive liposomes
72. Kinetics of the photoconversion of diphenylamine in β-cyclodextrin environments
73. Improvement of photostability of ubidecarenone in the formulation of a novel powdered dosage form termed redispersible dry emulsion
74. Photodecomposition and stabilization of compounds in dosage forms
75. Photoinstabilität und stabilisierung von arzneistoffen
76. Photoinstabilität von arzneimitteln. 3.Mitteilung: Photoinstabilität un stabilisierung von nifedipin in arzneiformen
77. Photoinstabilität von arzneimitteln 5.Mitteilung. Untersuchungen zur photostabilisierung von glukokortikoiden
78. Einfluss der wellenlänge auf die photozersetzung von arzneistoffen
79. Einfluss von hilfsstoffen auf die photozersetzung von arzneistoffen
80. Photo-responsive hydrogels for potential responsive release applications
81. The effect of pH, buffer type and drug concentration on the photodegradation of ciprofloxacin
82. Photochemical degradation of components in drug formulations. Part 1: An approach to the standardization of degradation studies
83. Photoreactivity of biologically active compounds. XV. Photochemical behaviour of mefloquine in aqueous solution
84. The ICH Photostability Guideline. A discussion of experimental conditions
85. Studies on curcumin and curcuminoids. X. The use of curcumin as a formulation aid to protect light-sensitive drugs in soft gelatin capsules
86. Photochemical degradation of components in drug formulations
87. Photochemical degradation of components in drug formulations. A discussion of experimental conditions
88. A comment on photostability testing according to the ICH guidelines: Calibration of light sources
89. Photoreactivity of biologically active compounds. XIII. Photostability of mefloquine hydrochloride in the solid state
90. Einfluss des sichtbaren lichtes auf die haltbarkeit von isoprenalin-, epinephrin- und levaterenollösungen in unterschiedlichen behältnissen
91. Photo-responsive degradation of heterogenous hydrogels comprising crosslinked hyaluronic acid and lipid microspheres for temporal drug delivery